Back to search
FDAFDA · Food and drugs·Recall number D-1585-2020

Potassium Acetate Injection, USP 40 mEq/20 mL (2 mEq/mL) Single Dose Vials, Rx only, Manufactured By: Exela Pharma Sciences, LLC. Lenoir, NC NDC 51754-2001-4

Published September 23, 2020 · Recall initiated: May 5, 2020

Summary

FDA records drug Class III recall D-1585-2020, published September 23, 2020 and initiated May 5, 2020. Recalling firm: Exela Pharma Sciences LLC; Status: Terminated; Reported quantity: 23,775 vials; Lot: Lot #P0000471, Catalog #2020TS002, Exp Date: 04/2021. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Short Fill

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Exela Pharma Sciences LLC
Distributor
Nationwide and Puerto Rico
Lot
Lot #P0000471, Catalog #2020TS002, Exp Date: 04/2021
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Potassium Acetate Injection, USP 40 mEq/20 mL (2 mEq/mL) Single Dose Vials, Rx only, Manufactured By: Exela Pharma Sciences, LLC. Lenoir, NC NDC 51754-2001-4 recalled?

Yes. FDA published recall D-1585-2020 on September 23, 2020. Reported hazard: Short Fill

What should I do if I have this product?

Voluntary: Firm initiated · Letter